Established as a partnership in global health, the Global Fund works closely with a wide diversity of partners –implementing governments, donors, civil society, international development organizations, the private sector and communities living with and affected by the diseases. This partnership model actively supports country-owned approaches that develop and implement effective, evidence-based programs to respond to AIDS, tuberculosis and malaria.
The Global Fund is a private foundation whose purpose is to raise, manage and disburse additional funding to countries to support them in their fight against the three diseases. As such, it does not implement or manage programs on the ground, relying instead on the expertise of partners.
The partnership model of the Global Fund rests on seven core structures.
The Global Fund Secretariat is responsible for the day-to-day functioning of the organization. This includes: management of the grant portfolio; disbursement of funds to countries; monitoring and evaluation of program results; relationships with current and potential donors; and communications and resource mobilization activities. The Secretariat is composed of roughly 600 staff members and is based in Geneva, Switzerland; it has no staff located outside its headquarters.
Governance of the Global Fund is the responsibility of the Board, which is composed of representatives from donor and recipient governments, civil society, the private sector, private foundations, and communities living with and affected by the diseases. The Board consists of 20 voting constituencies and eight non-voting advisory seats. The six main areas of work of the Board are: strategy, governance, financial, performance, risk, and external relations.
Each country supported by the Global Fund has a Country Coordinating Mechanism, composed of representatives of all key stakeholders involved in the response to the three diseases, and in particular representatives of communities living with the diseases. The role of the Country Coordinating Mechanism is to write and submit a request for funding on behalf of the entire country, and to oversee the implementation of the program once the request for funding has been approved.
Each request for funding will be evaluated by the Technical Review Panel. This is a body of independent experts that assesses a country’s proposal against technical and scientific criteria, taking into account the country’s epidemiological situation and needs.
The work of implementing a grant is carried out by one or more organizations within the country known as Principal Recipient(s). These can be any type of organization – government ministry, faith-based organization, NGO – and they are tasked with the financial and programmatic responsibility for the grant. In addition, many Principal Recipients further disburse funding to other, smaller organizations known as sub-recipients.
Principal Recipients must report regularly on the progress of their grants, both on how the money was spent and, in particular, on the results obtained with that funding. This information is submitted to and verified by independent consultancies in each country known as Local Fund Agents. These organizations serve as the Global Fund’s “eyes and ears on the ground”, assessing the capacity of implementers and verifying the data submitted.
Global Fund grants receive further oversight through the work of the Inspector General, who is responsible for carrying out audits of country programs and investigating any potential cases of fraud and abuse. The Office of the Inspector General has a whistle-blowing hotline available for anyone who wishes to report suspicious activity. The Inspector General reports directly to the Board and is entirely independent of the Secretariat.
Further information on each of these core structures is available at the links shown above.
Country Coordinating Mechanisms
Local Fund Agents
Market Dynamics Advisory Group (MDAG)
Office of the Inspector General
Contact | Report Fraud and Abuse | Legal | RSS | Sitemap
© 2014 The Global Fund to Fight AIDS, Tuberculosis and Malaria